This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: University of Utah Research Foundation. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Kwangsuk Lim: Innovator in Bi-functional Allosteric Protein-Drug Molecules
Introduction
Kwangsuk Lim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of targeted therapy through his innovative research and development of bi-functional allosteric protein-drug molecules. His work aims to enhance the efficacy of cancer treatments.
Latest Patents
Kwangsuk Lim holds a patent for a bi-functional allosteric protein-drug molecule designed for targeted therapy. This invention comprises a targeting moiety, one or more biological binding domains, and one or more therapeutic agents. The therapeutic agent is allosterically bound to the biological binding domain, allowing for more precise treatment options. The patent also describes methods for incorporating these molecules into physiologically acceptable compositions and administering them to patients for cancer treatment.
Career Highlights
Kwangsuk Lim is affiliated with the University of Utah Research Foundation, where he continues to advance his research in bi-functional allosteric protein-drug molecules. His work is pivotal in the ongoing quest to develop more effective cancer therapies.
Collaborations
Kwangsuk Lim has collaborated with notable colleagues, including David A Bull and Youngwook Won. These partnerships have contributed to the advancement of his research and the development of innovative therapeutic solutions.
Conclusion
Kwangsuk Lim's contributions to the field of targeted therapy through his patented bi-functional allosteric protein-drug molecules represent a significant advancement in cancer treatment. His ongoing research and collaborations continue to pave the way for innovative solutions in medicine.